M P Davis
Affiliation: Cleveland Clinic Foundation
- Davis M, Khawam E, Pozuelo L, Lagman R. Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project. Expert Rev Anticancer Ther. 2002;2:365-76 pubmed..The pharmacokinetics and pharmacodynamics of both agents are unique and explain many of the benefits. More research and clinical experience will be necessary to define their role in the palliation of advanced cancer. ..
- Davis M. New therapies for antiemetic prophylaxis for chemotherapy. J Community Support Oncol. 2016;14:11-20 pubmed publisher..Compliance to guidelines in multiple settings ranges from 50%-60% but is improved by computerized order entry of antiemetics and recommendations displayed with chemotherapy. ..
- Davis M, Hallerberg G. A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation. J Pain Symptom Manage. 2010;39:756-67 pubmed publisher..Therefore, a systematic review based on the question "What is the evidence that supports antiemetic choices in advanced cancer?" guided this review...